Momordica charantia L. for hyperlipidaemia: A randomised controlled assessment of the Ghanaian herbal medicinal product MCP-1
No Thumbnail Available
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Cardiovascular diseases are a public health burden for developing countries like Ghana. Scientifically validated
herbal medicines are viable options in the prevention and treatment of such conditions. In this study, a rand omised controlled trial involving 15 healthy subjects identified with hyperlipidaemia was undertaken. Treatment
comprised a traditional Ghanaian herbal formulation prepared from the leaves and twines of Momordica char antia (MCP-1) with a standard dietary guideline. A control group was managed using a standard dietary guideline
alone. In all, 15 subjects completed the study: MCP-1 had 10 subjects and 5 subjects in the control group. At the
termination of the trial after 8 weeks, reduction in lipoprotein values were recorded for all participants. In the
MCP-1 group, triglycerides reduced by 3.46 % compared to 3.37 % for the control while total cholesterol was
also reduced by 9.78 % and 9.43 % in the MCP-1 and control groups respectively. High density lipoproteins
(HDL) levels increased by 6.92 % for MCP-1 and 3.92 % for the control group. However, these changes were not
statistically significant except in the instance of the low-density lipoproteins (LDL-c; CI: -41.24 to -19.76) and
very low-density lipoproteins (VLDL-c; CI: -26.87 to -8.192). Changes to other disease indices such as blood
pressure (BP), fasting blood sugar (FBS) and body mass index (BMI) were also not different between the 2 groups.
MCP-1 was well tolerated among the subjects and was shown to be safe from the biochemical and haematological
indicators. The product, MCP-1 has therefore been shown to be a safe and prospective anti-lipidaemic agent.
Description
This article is published by Elsevier and is also available at https://doi.org/10.1016/j.hermed.2021.100453
Keywords
Citation
Journal of Herbal Medicine 28 (2021) 100453